0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

news@JAMA | 
JAMA. 2014;311(18):1845. doi:10.1001/jama.2014.4808.

JAMA Clinical Challenge | 
Najim Lahrouchi, MD; Machteld I. Bosscha, MD; Annette C. Moll, MD, PhD
JAMA. 2014;311(17):1799-1800. doi:10.1001/jama.2013.286248.

Clinical Trials Update | 
Anita Slomski
JAMA. 2013;310(24):2605. doi:10.1001/jama.2013.284384.

Original Contribution |  FREE
Melissa M. Hudson, MD; Kirsten K. Ness, PT, PhD; James G. Gurney, PhD; et al.
JAMA. 2013;309(22):2371-2381. doi:10.1001/jama.2013.6296.
Includes: CME, Supplemental Content

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2013;309(17):1765. doi:10.1001/jama.2013.4803.

Global Health | 
M. J. Friedrich
JAMA. 2013;309(15):1578. doi:10.1001/jama.2013.4120.

Editorial | 
Kimberly F. Whelan, MD, MSPH; Frederick D. Goldman, MD
JAMA. 2012;307(24):2639-2641. doi:10.1001/jama.2012.6975.

Capitol Health Call | 
Mike Mitka
JAMA. 2011;306(18):1970. doi:10.1001/jama.2011.1602.

Original Contribution |  FREE
Raoul C. Reulen, PhD; Clare Frobisher, PhD; David L. Winter; et al.
JAMA. 2011;305(22):2311-2319. doi:10.1001/jama.2011.747.
Includes: Supplemental Content

Medical News & Perspectives | 
M. J. Friedrich
JAMA. 2011;305(22):2276-2278. doi:10.1001/jama.2011.778.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Ophthalmology
Editorial  | 
Retinoblastoma:  The Zimmerman Family Story
Mary Louise Z. Collins, MD
JAMA Ophthalmology
Original Investigation  | 
Combined Intravitreal Melphalan and Topotecan for Refractory or Recurrent Vitreous Seeding From Retinoblastoma
Fariba Ghassemi, MD; Carol L. Shields, MD; Hadi Ghadimi, MD; et al.
JAMA Ophthalmology
Original Investigation  | 
Retinoblastoma Incidence Patterns in the US Surveillance, Epidemiology, and End Results Program
Jeannette R. Wong, MPH; Margaret A. Tucker, MD; Ruth A. Kleinerman, MPH; et al.
JAMA Ophthalmology
Original Investigation  | 
Intravitreal Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds:  Preliminary Results
Carol L. Shields, MD; Fairooz P. Manjandavida, MD; Sruthi Arepalli, BA; et al.